Forest Hill Capital’s AbbVie ABBV Stock Holding History

Forest Hill Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$906K	Hold	3,600	–	–	0.7%	9
2026 Q1	$783K	Hold	3,600	–	–	0.51%	13
2025 Q4	$823K	Sell	3,600 -600	-14%	-$137K	0.42%	29
2025 Q3	$972K	Hold	4,200	–	–	0.57%	29
2025 Q2	$780K	Hold	4,200	–	–	0.55%	30
2025 Q1	$880K	Hold	4,200	–	–	0.66%	30
2024 Q4	$746K	Buy	4,200 +600	+17%	+$110K	0.58%	33
2024 Q3	$711K	Hold	3,600	–	–	0.54%	36
2024 Q2	$617K	Hold	3,600	–	–	0.51%	34
2024 Q1	$656K	Hold	3,600	–	–	0.56%	33
2023 Q4	$558K	Hold	3,600	–	–	0.29%	42
2023 Q3	$537K	Hold	3,600	–	–	0.28%	40
2023 Q2	$485K	Hold	3,600	–	–	0.23%	44
2023 Q1	$574K	Hold	3,600	–	–	0.25%	43
2022 Q4	$582K	Hold	3,600	–	–	0.25%	41
2022 Q3	$483K	Hold	3,600	–	–	0.21%	42
2022 Q2	$551K	Hold	3,600	–	–	0.23%	40
2022 Q1	$584K	Buy	+3,600	New	+$523K	0.15%	46

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Forest Hill Capital's ABBV Position: Q2 2026 in Review

Forest Hill Capital held its AbbVie (ABBV) position steady in Q2 2026 at 3,600 shares worth $906K. The position accounts for 0.7% of the portfolio, ranked #9.

Forest Hill Capital first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $972K in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Forest Hill Capital held 3,600 shares of AbbVie worth $906K as of Q2 2026.
Forest Hill Capital left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.7% of Forest Hill Capital's portfolio in Q2 2026, its #9 holding.
Forest Hill Capital first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
Forest Hill Capital's AbbVie position peaked at $972K in Q3 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Forest Hill Capital's 13F filing for Q2 2026, filed 14 Aug 2026.